Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2021 02:30 ET | Source: Active Biotech

Active Biotech Bokslutsrapport 2020

Ny strategisk FoU-plan genomförd och finansierad HÄNDELSER UNDER KVARTAL 4Tasquinimod Den kliniska studien i multipelt myelom presenterades muntligt på mötet American Society of Hematology (ASH)...
February 11, 2021 02:30 ET | Source: Active Biotech

Active Biotech Year-end report January – December 2020

New strategic R&D plan implemented and financed Fourth quarter in briefTasquinimod The clinical study in multiple myeloma was presented at an oral poster session at the virtual American...
February 04, 2021 09:00 ET | Source: Active Biotech

ACTIVE BIOTECH INGÅR TILLVERKNINGSAVTAL MED FAMAR HEALTH CARE SERVICES FÖR NY FORMULERING AV LAQUINIMOD

Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) meddelade idag att de har ingått ett tillverkningsavtal med Famar Health Care Services Madrid SAU ("Famar"), en europeisk leverantör av...
February 04, 2021 09:00 ET | Source: Active Biotech

ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD

Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services Madrid SAU (“Famar”), a European provider of pharmaceutical...
January 26, 2021 05:00 ET | Source: Active Biotech

Active Biotechs företrädesemission kraftigt övertecknad

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, JAPAN ELLER KANADA ELLER I NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTION AV DETTA...
January 26, 2021 05:00 ET | Source: Active Biotech

Active Biotech’s rights issue heavily oversubscribed

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION...
January 07, 2021 08:15 ET | Source: Active Biotech

Justering av period för handel med teckningsrätter och BTA i Active Biotechs företrädesemission

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, JAPAN ELLER KANADA ELLER I NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTION AV DETTA...
January 07, 2021 08:15 ET | Source: Active Biotech

Adjustment of period for trading in subscription rights and interim shares in Active Biotech’s rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION...
January 05, 2021 08:00 ET | Source: Active Biotech

Active Biotech offentliggör prospekt och viss ny finansiell information som återfinns i prospektet

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, JAPAN ELLER KANADA ELLER I NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTION AV DETTA...
January 05, 2021 08:00 ET | Source: Active Biotech

Active Biotech publishes prospectus and certain new financial information included in the prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION...